Taylor, P., Downie, B., Elboudwarej, E., Kim, S., Hertz, A., Mirza, A., . . . Liu, J. (2020). Whole blood transcriptional changes following selective inhibition of janus kinase 1 (JAK1) by filgotnib in adults with moderately-to-severely active rheumatoid arthritis with prior inadequate response to methotrexate (FINCH1). BMJ.
Chicago Style (17th ed.) CitationTaylor, PC, B. Downie, E. Elboudwarej, S. Kim, A. Hertz, AM Mirza, J. Siegel, RE Hawtin, and J. Liu. Whole Blood Transcriptional Changes Following Selective Inhibition of Janus Kinase 1 (JAK1) by Filgotnib in Adults with Moderately-to-severely Active Rheumatoid Arthritis with Prior Inadequate Response to Methotrexate (FINCH1). BMJ, 2020.
MLA (9th ed.) CitationTaylor, PC, et al. Whole Blood Transcriptional Changes Following Selective Inhibition of Janus Kinase 1 (JAK1) by Filgotnib in Adults with Moderately-to-severely Active Rheumatoid Arthritis with Prior Inadequate Response to Methotrexate (FINCH1). BMJ, 2020.